As the saying goes, the more things change, the more they stay the same – and the world of health care fraud enforcement is no exception. Recent years have seen a wave of novel technologies, emerging threats to our nation’s...more
As President-Elect Trump’s second Administration begins in January 2025, businesses face a critical juncture with potential shifts in regulatory focus across industries and sectors including artificial intelligence,...more
11/13/2024
/ Artificial Intelligence ,
Chevron Deference ,
Consumer Financial Protection Bureau (CFPB) ,
Cryptocurrency ,
Data Privacy ,
Department of Defense (DOD) ,
Department of Justice (DOJ) ,
Environmental Protection Agency (EPA) ,
Ethics ,
Federal Contractors ,
Federal Election Commission (FEC) ,
Healthcare ,
International Trade ,
National Security ,
Presidential Elections ,
Regulatory Reform ,
Securities and Exchange Commission (SEC) ,
Toxic Substances Control Act (TSCA) ,
Trump Administration ,
USTelecom
WHAT: The U.S. Supreme Court handed down its much-anticipated decision in United States ex rel. Schutte v. SuperValu Inc. The Court considered the narrow issue of whether the False Claims Act’s (FCA) scienter requirement...more
6/2/2023
/ Drug Pricing ,
False Claims Act (FCA) ,
Healthcare ,
Pharmaceutical Industry ,
Prescription Drugs ,
Reasonable Interpretations ,
Safeco Insurance Co of America v Burr ,
Scienter ,
SCOTUS ,
US ex rel Thomas Proctor v Safeway Inc ,
US ex rel Tracy Schutte et al v SuperValu Inc et al